Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis

NCT05942911 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment challenges

Conditions

Rheumatoid Arthritis

Interventions

DRUG: IHL-675A
DRUG: Cannabidiol
DRUG: Hydroxychloroquine
DRUG: Placebo

Sponsor

Incannex Healthcare Ltd